Sponsor

Gentofte Hospital

Denmark Gentofte Hospitalsvej 1, 2900 Hellerup, Denmark

About the sponsor

Research activity includes influenza, RSV infection, SARS-CoV-2 infection, and herpes zoster, with attention to prevention of severe respiratory outcomes and vaccine-related immune responses in older adults.

Influenza vaccination
COVID-19 prevention
RSV-related respiratory disease
Herpes zoster vaccination

Studies also examine mucosal immunity and innate immune training after live or intranasal vaccination strategies.

About Specializations

Gentofte Hospital runs clinical trials in conditions such as Influenza, COVID-19, Type 1 diabetes mellitus, Hidradenitis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

24 clinical trials

COVID-19+1

Recruiting

Effectiveness of mCOMBRIAX vaccine compared with high‑dose influenza vaccine and mRNA‑1273 in adults ≥65 years for prevention of influenza and COVID‑19

Registered drugNo placebo

Effectiveness of mCOMBRIAX vaccine compared with high‑dose influenza vaccine and mRNA‑1273 in adults ≥65 years for prevention of influenza and COVID‑19

Registered drugNo placebo

Denmark

Participants:65+ years · Healthy volunteers
Substances:B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)
Sponsor:Gentofte Hospital

Contact Research Centre

Hypersensitivity+1

Recruiting

A Study Testing Prolonged versus Single Dose Penicillin Challenge in Patients with Suspected Penicillin Allergy Using Amoxicillin

Investigational

A Study Testing Prolonged versus Single Dose Penicillin Challenge in Patients with Suspected Penicillin Allergy Using Amoxicillin

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Amoxicillin Trihydrate
Sponsor:Austin Health

Contact Research Centre

Type 1 diabetes mellitus

Recruiting

Study of colchicine to improve insulin sensitivity in adults with type 1 diabetes who have low-grade inflammation

Registered drug

Study of colchicine to improve insulin sensitivity in adults with type 1 diabetes who have low-grade inflammation

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Colchicine
Sponsor:Gentofte Hospital

Contact Research Centre

Hidradenitis

Recruiting

Study on Botulinum Toxin Type A for Treating Hidradenitis Suppurativa in Patients: A Comparison of Different Drug Combinations

Registered drug

Study on Botulinum Toxin Type A for Treating Hidradenitis Suppurativa in Patients: A Comparison of Different Drug Combinations

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Frederiksberg Hospital

Contact Research Centre

Pneumonia

Recruiting

Study on Inhaled Levofloxacin and Sodium Chloride for Patients with Community-Acquired Pneumonia, Including Those with Pre-existing Lung Disease

Registered drug

Study on Inhaled Levofloxacin and Sodium Chloride for Patients with Community-Acquired Pneumonia, Including Those with Pre-existing Lung Disease

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Levofloxacin
Sponsor:Gentofte Hospital

Contact Research Centre

Pneumonia

Recruiting

Study on Inhaled Levofloxacin for Treating Community-Acquired Pneumonia in Patients Without Systemic Antibiotics

Registered drugNo placebo

Study on Inhaled Levofloxacin for Treating Community-Acquired Pneumonia in Patients Without Systemic Antibiotics

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Levofloxacin
Sponsor:Gentofte Hospital

Contact Research Centre

Atrial fibrillation

Recruiting

Study on Colchicine for Reducing Atrial Fibrillation Recurrence in Patients Undergoing Electrical Cardioversion

Registered drug

Study on Colchicine for Reducing Atrial Fibrillation Recurrence in Patients Undergoing Electrical Cardioversion

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Autumn Crocus Fresh Flower Fluid Extract (1:15-25), Extraction Solvent Ethanol 96% (V/V)
Sponsor:Gentofte Hospital

Contact Research Centre

Hidradenitis

Not yet recruiting

Adalimumab, Doxycycline, and Resorcinol for Adults with Early Hidradenitis Suppurativa at High Risk of Progression to Severe Disease

Registered drugNo placebo

Adalimumab, Doxycycline, and Resorcinol for Adults with Early Hidradenitis Suppurativa at High Risk of Progression to Severe Disease

Registered drugNo placebo

Denmark

Participants:18–64 years
Substances:Adalimumab
Sponsor:Gentofte Hospital

Contact Research Centre

Obesity

Not yet recruiting

A study of orismilast alone or combined with semaglutide for weight management in people with obesity

Registered drug

A study of orismilast alone or combined with semaglutide for weight management in people with obesity

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Orismilast
Sponsor:Gentofte Hospital

Contact Research Centre

Chronic kidney disease

Not yet recruiting

Study on the Effects of Dapagliflozin on Heart Function in Patients with Chronic Kidney Disease

Registered drug

Study on the Effects of Dapagliflozin on Heart Function in Patients with Chronic Kidney Disease

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Dapagliflozin Propanediol
Sponsor:Gentofte Hospital

Contact Research Centre

Herpes zoster

Not recruiting

Evaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster

Registered drugNo placebo